Antibacterial activity of trichorabdal a from Rabdosia trichocarpa against Helicobacter pylori

Zentralblatt fur Bakteriologie

Volumn 286, Issue 1, 1997, Pages 63-67

  Kadota, Shigetoshi ^a   Basnet, Purusotam ^a   Ishii, Eiji ^b   Tamura, Toshihide ^c   Namba, Tsuneo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b OSAKA CITY INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HELICOBACTER PYLORI; RABDOSIA TRICHOCARPA;

EID: 0031170918     PISSN: 09348840     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0934-8840(97)80076-X     Document Type: Article

References (13)

1. Adamek, R. J., M. Wegner, J. Labenz, M. Freitag, W. Opferkuch, and G. H. Ruhl: Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Am. J. Gastroenterol. 89 (1994) 39-42
2. Bazzoli, F., R. M. Zagari, S. Fossi, P. Pozzato, G. Alampi, P. Simoni, S. Sottili, A. Roda, and E. Roda: Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 6 (1994) 773-777
3. Fuji, K., M. Node, M. Sai, E. Fujita, T. Shingu, W. H. Watson, D. A. Grossie, and V. Zabel: Terpenoids LI. Structure and antitumor diterpenoids, Trichorabdals A-E, isolated from Rabdosia trichocarpa. Chem. Pharm. Bull. 37 (1989) 1465-1469
4. Fuji, K., M. Node, M. Sai, E. Fujita, S. Takeda, and N. Unemi: Terpenoids LIII. Antitumor activity of Trichorabdals and related compounds. Chem. Pharm. Bull. 37 (1989) 1472-1476
5. Fujita, E., Y. Nagao, K. Kaneko, S. Nakazawa, and H. Kuroda: The antitumor and antibacterial activity of the isodon diterpenoids. Chem. Pharm. Bull. 24 (1983) 2118-2127
6. Ishii, E.: Antibacterial activity of Teprenone, a non water-soluble antiulcer agent, against Helicobacter pylori. Zbl. Bakt. 280 (1993) 239-243
7. Ishii, E. and T. Kishi: Differences in susceptibilities of Helicobacter pylori to macrolide and other antibiotics in tests using blood agar and albumin agar. J. Jap. Assoc. Infect. Dis. 67 (1993) 137-142
8. McNulty, C. A. M., J. C. Gearty, B. Crump, M. Davis, I. A. Donavan, V. Melikian, D. M. Lister, and R. Wise: Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Brit. Med. J. 293 (1986) 645-649
9. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. J. Am. Med. Assoc. 272 (1994) 65-69
10. Node, M., M. Sai, K. Fuji, E. Fujita, S. Takeda, and N. Unemi: Antitumor activity of diterpenoids, trichorabdals A, B, C and the related compounds: Synergism of two active sites. Chem. Pharm. Bull. 31 (1983) 1433-1436
11. Nomura, A., G. N. Stemmermann, P.-H. Chyou, I. Kato, G. I. Perez-Perez, and M. J. Blaser: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 325 (1991) 1132-1136
12. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley: Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325 (1991) 1127-1131
13. Somal, N. A., K. E. Coley, P. C. Molan, and B. M. Hancock: Susceptibility of Helicobacter pylori to the antibacterial activity of manuka honey. J. Roy. Soc. Med. 87 (1994) 9-12